ClinicalTrials.gov record
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer
ClinicalTrials.gov ID: NCT03901339
Public ClinicalTrials.gov record NCT03901339. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 3 Study of Sacituzumab Govitecan (IMMU-132) Versus Treatment of Physician's Choice (TPC) in Subjects With Hormonal Receptor-Positive (HR+) Human Epidermal Growth Factor Receptor 2 (HER2) Negative Metastatic Breast Cancer (MBC) Who Have Failed at Least Two Prior Chemotherapy Regimens
Study identification
- NCT ID
- NCT03901339
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Gilead Sciences
- Industry
- Enrollment
- 543 participants
Conditions and interventions
Conditions
Interventions
- Capecitabine Drug
- Eribulin Drug
- Gemcitabine Drug
- Sacituzumab Govitecan-hziy Drug
- Vinorelbine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 7, 2019
- Primary completion
- Oct 19, 2023
- Completion
- Oct 19, 2023
- Last update posted
- Oct 20, 2024
2019 – 2023
United States locations
- U.S. sites
- 55
- U.S. states
- 24
- U.S. cities
- 43
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| HonorHealth Research Institute | Avondale | Arizona | 85392 | — |
| Arizona Oncology Associates, PC | Tucson | Arizona | 85704 | — |
| Highlands Oncology Group | Fayetteville | Arkansas | 72703 | — |
| University of California, San Diego Moores Cancer Center | La Jolla | California | 92093 | — |
| Los Angeles Hematology Oncology Medical Group | Los Angeles | California | 90017 | — |
| UCLA Department of Medicine - Hematology/Oncology | Los Angeles | California | 90095 | — |
| University of California, Irvine Medical Center-Chao Family Comprehensive Cancer Center | Orange | California | 92868 | — |
| Southern California Permanente Medical Group | San Diego | California | 92120 | — |
| UCSF Helen Diller Family Comprehensive Cancer Center | San Francisco | California | 94115 | — |
| Rocky Mountain Cancer Centers | Aurora | Colorado | 80012 | — |
| University of Colorado | Aurora | Colorado | 80045 | — |
| Yale University Cancer Center | New Haven | Connecticut | 06520 | — |
| Georgetown University Medical Center | Washington D.C. | District of Columbia | 20007 | — |
| University of Miami - Sylvester Comprehensive Cancer Center | Miami | Florida | 33136 | — |
| Miami Cancer Institute | Miami | Florida | 33176 | — |
| Orlando Health, Inc. | Orlando | Florida | 32806 | — |
| Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| Emory University - Winship Cancer Institute | Atlanta | Georgia | 30322 | — |
| Northside Hospital, Inc. | Atlanta | Georgia | 30342 | — |
| University of Chicago Medical Center | Chicago | Illinois | 60637 | — |
| The University of Kansas Cancer Center | Westwood | Kansas | 66205 | — |
| James Graham Brown Cancer Center | Louisville | Kentucky | 40202 | — |
| Mercy Medical Center, Medical Oncology & Hematology | Baltimore | Maryland | 21202 | — |
| Maryland Oncology Hematology, P.A. | Rockville | Maryland | 20850 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | — |
| Allina Health, Virginia Piper Cancer Institute | Minneapolis | Minnesota | 55407 | — |
| Masonic Cancer Center, University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Saint Luke's Cancer Institute | Kansas City | Missouri | 64111 | — |
| Washington University School of Medicine - Siteman Cancer Center | St Louis | Missouri | 63110 | — |
| St. Vincent Frontier Cancer Center | Billings | Montana | 59102 | — |
| Summit Medical Group | Florham Park | New Jersey | 07932 | — |
| Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | 08903 | — |
| New York Oncology Hematology, P.C. | Albany | New York | 12206 | — |
| Laura and Isaac Perlmutter Cancer Center/NYU Langone Health | New York | New York | 10016 | — |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| The Ohio State University | Columbus | Ohio | 43210 | — |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| Magee-Womens Hospital of UPMC | Pittsburgh | Pennsylvania | 15213 | — |
| The West Clinic, PC dba West Cancer Center | Germantown | Tennessee | 38138 | — |
| Tennessee Oncology, PLLC | Nashville | Tennessee | 37203 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| Texas Oncology-Baylor Charles A. Sammons Cancer Center | Dallas | Texas | 75246 | — |
| University of Texas Southwestern Harold C. Simmons Comprehensive Cancer Center | Dallas | Texas | 75390 | — |
| Texas Oncology-Denton South | Denton | Texas | 76210 | — |
| Houston Methodist Hospital/Houston Methodist Cancer Center | Houston | Texas | 77030 | — |
| Texas Oncology-Longview Cancer Center | Longview | Texas | 75601 | — |
| UT Health San Antonio - Mays Cancer Center | San Antonio | Texas | 78229 | — |
| Virginia Cancer Specialists | Arlington | Virginia | 22205 | — |
| Virginia Oncology Associates | Norfolk | Virginia | 23502 | — |
| Oncology & Hematology Associates of Southwest Virginia, Inc. DBA Blue Ridge Cancer Care | Salem | Virginia | 24153 | — |
| Northwest Medical Specialties, PLLC | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 58 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03901339, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 20, 2024 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03901339 live on ClinicalTrials.gov.